Kabra Drugs Limited (BOM:524322)
25.43
-0.67 (-2.57%)
At close: Jun 17, 2026
108.27% (1Y)
| Market Cap | 602.89M +494.6% |
| Revenue (ttm) | 927.40M |
| Net Income | 49.60M |
| EPS | 2.09 |
| Shares Out | 23.71M |
| PE Ratio | 12.17 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 91,404 |
| Open | 26.98 |
| Previous Close | 26.10 |
| Day's Range | 25.25 - 26.98 |
| 52-Week Range | 12.21 - 35.52 |
| Beta | -0.10 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 29, 2026 |